PATENT CLAIM ANALYSIS

Application Number: 15756919
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "023000"]

Abstract:
The present invention relates to a composition for preventing or treating lipid-related metabolic diseases. The composition according to the present invention comprises D-psicose as an active ingredient. D-psicose has the ability to inhibit lipid absorption in the small intestine and considerably increase lipid levels in feces. Due to its ability, D-psicose is effective in inhibiting the formation of body fat. In addition, D-psicose reduces body weight, body fat mass, and plasma lipid to normal levels to normalize body weight, body fat mass, and plasma lipid profiles. Due to these advantages, D-psicose is expected to find application in pharmaceutical drugs, health functional foods, and functional foods suitable for preventing and/or treating lipid-related metabolic diseases.

Claim (Index 2):
A method for inhibiting an absorption of an ingested lipids in a subject, promoting an excretion of the ingested lipids in the subject, or both, comprising administering the composition of  claim 1  to the subject the subject.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.91045
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13256461', '13580481', '15334616', '14778379', '13056805']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7278468937725479
- 35 USC 102 Novelty (BERT): 0.5300462792152444
- Combined Prediction Score: 0.7080668323168176
- Mean Citation Score: 264.082374
- Max Citation Score: 288.88046
- Similarity Product: 153.93187220164896

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test